P367 PHASE 2 STUDY EVALUATING THE EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS WHO HAD AN INADEQUATE RESPONSE TO URSODEOXYCHOLIC ACID

Journal article

Peer reviewed

G.M. Hirschfield, M.E. Gershwin, R. Strauss, M.J. Mayo, C. Levy, B. Zou, C. Selmi, H.-U. Marschall and K. Lindor

Journal of hepatology, Vol.60(1), pp.S189-S190

2014-04

Metrics

3 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.125 Hepatitis; 1.125.1515 Primary Biliary Cirrhosis
Web Of Science research areas: Gastroenterology & Hepatology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: P367 PHASE 2 STUDY EVALUATING THE EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS WHO HAD AN INADEQUATE RESPONSE TO URSODEOXYCHOLIC ACID
Creators: G.M. Hirschfield
M.E. Gershwin
R. Strauss
M.J. Mayo
C. Levy
B. Zou
C. Selmi
H.-U. Marschall
K. Lindor
Publication Details: Journal of hepatology, Vol.60(1), pp.S189-S190
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031714074102976